Trial intelligence / Profile preview

Phase III trial of D-PLEX plus standard of care for prevention of abdominal surgical site infection

2020-002325-28Phase 3Completed

Sponsor
PolyPid Ltd.
Start
Aug 2020
Modality
Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in surgical site infection (SSI) comparing D-PLEX + standard of care with Control standard of care (2 arms). Primary endpoint: Infection rate. Started Aug 2020; status: completed.

02

Drugs

D-PLEX100
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on 2020-002325-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-002325-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call